Montalbano John S.
SEC CIK 1834423 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABCL | AbCellera Biologics Inc. | Dir | 251.0K | $1.09M | — | 9 | 2021-08-16 | 2026-08-18 |
Most active insiders at ABCL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hayden Michael R | Dir | $1.05M | — |
| 2 | Thermopylae Holdings Ltd. | 10% | $711.0K | — |
| 3 | Booth Andrew | CFO | $529.6K | — |
| 4 | Montalbano John S. | Dir | $384.2K | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 14:45 | 2026-08-18 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $11.03 | +10.0K | 251.0K | +4% | +$110.3K | |
| 2026-05-18 12:09 | 2026-05-14 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $4.77 | +20.0K | 241.0K | +9% | +$95.4K | |
| 2025-11-26 | 2025-11-26 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $3.57 | +50.0K | 221.0K | +29% | +$178.5K | |
| 2025-03-10 | 2025-03-10 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $2.30 | +25.0K | 171.0K | +17% | +$57.5K | |
| 2025-03-07 | 2025-03-06 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $2.34 | +60.0K | 146.0K | +70% | +$140.4K | |
| M | 2023-11-08 | 2023-11-06+ | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $4.58 | +30.0K | 76.0K | +65% | +$137.4K |
| 2022-03-04 | 2022-03-04 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $8.54 | +10.0K | 56.0K | +22% | +$85.4K | |
| 2022-03-03 | 2022-03-01 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $9.05 | +20.0K | 46.0K | +77% | +$181.0K | |
| 2021-08-17 | 2021-08-16 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Dir | P - Purchase | $17.23 | +6,000 | 26.0K | +30% | +$103.4K |
Purchase Sale Sale after option exercise All abbreviations